Gelonghui, April 12, 丨 Mengke Pharmaceutical (688373.SH) announced that as of April 11, 2024, the increase holder had accumulated 569,800 shares of the company's shares through centralized bidding through the Shanghai Stock Exchange trading system, accounting for 0.087% of the company's total share capital, with a total increase of 2,951,649 yuan. The implementation of this holdings increase plan has been completed.

The shareholders, directors and senior management personnel of more than 5% of the company's shareholders include: MICURX (HK) LIMITED (hereinafter referred to as “Mengke Hong Kong”), the company's chairman and general manager Mr. ZHENGYU YUAN (Yuan Zhengyu), the company's director, deputy general manager, chief financial officer and board secretary, Mr. Wang Xinghai, the company's deputy general manager, and Mr. Zhao Dongming, the company's deputy general manager.